5-19.1-36.1. Pharmacists -- Drug categories -- Prescribing.

(a) In accordance with this chapter and regulations adopted by the department of health, a

pharmacist may engage in the independent prescribing of drugs, drug categories, or devices that

are critical to the improvement of public health in accordance with such products' federal Food and

Drug Administration-approved labeling:

(1) Drugs for medication assisted treatment (MAT) of opioid use disorder;

(2) Nicotine/tobacco cessation products;

(3) Hyperlipidemia medications;

(4) Inhalers for COPD or asthma;

(5) Insulin and diabetes medications;

(6) Drugs to treat hypertension;

(7) Treatment for positive infectious disease point-of-care testing for influenza, COVID-

19, group A strep, and other infections approved by the director;

(8) Such other drugs, drug categories, or devices set forth in the regulations promulgated

by the department of health in collaboration with the board of pharmacy. A prescribing pharmacist

25 may order and review and clinical laboratory test necessary to appropriately prescribe and manage

drugs and devices in accordance with this section.